Introduction
============

Dietary fiber may be considered the 'dinosaur' of functional foods. The hypolipidemic effects and cardioprotective benefits associated with dietary soluble fiber consumption are abundantly clear from the results of human clinical trials ([@b7-vhrm-4-1023], [@b8-vhrm-4-1023], [@b5-vhrm-4-1023]; [@b12-vhrm-4-1023]; [@b15-vhrm-4-1023]; [@b80-vhrm-4-1023]), animal feeding studies ([@b107-vhrm-4-1023]; [@b109-vhrm-4-1023]), epidemiological investigations ([@b63-vhrm-4-1023]), and meta-analysis reports ([@b90-vhrm-4-1023]; [@b4-vhrm-4-1023]; [@b6-vhrm-4-1023]; [@b23-vhrm-4-1023]). Furthermore, the mechanisms by which soluble fibers modulate cholesterol metabolism and effectively reduce circulating cholesterol concentrations have been the subject of many published reports ([@b34-vhrm-4-1023]; [@b85-vhrm-4-1023]). Such an extensive research history begs the question: Is the fiber story over? Advancements in any biological discipline often require an assessment of current knowledge and a reflection on what is not understood or has yet to be pursued. The objective of this review is to assess what is known regarding the role of soluble dietary fiber in modulating cholesterol metabolism and reducing cardiovascular disease risk. To contextualize the place of fiber in modern human health and disease prevention, we will begin with a brief account of the history of dietary fiber research and the modern dietary fiber classification system. An additional objective of this review article is to explore what is known regarding the mechanisms by which fiber consumption is thought to reduce plasma cholesterol concentrations. Finally, with the modern emphasis on molecular nutrition and the application of 'high-dimensional biology' or 'omic' technology, we will review recent progress in understanding how fiber consumption may regulate the enterohepatic metabolism of cholesterol at the molecular level and highlight current research priorities that will advance our existing knowledge base.

A brief history of dietary fiber
================================

In the mid 1970s, as the controversy surrounding the role of cholesterol in atherosclerosis resached an unparalleled point of contention within the medical community ([@b99-vhrm-4-1023], [@b100-vhrm-4-1023]), the dietary fiber hypothesis emerged as the new paradigm of nutrition in human health and disease prevention. While modern dietary fiber nutrition stemmed from observational and epidemiological studies in the 1970s, the hypothesis that the consumption of coarse foods of plant origin could modulate human health was not an entirely new concept. As early as 430 BC, Hippocrates understood the link between dietary fiber and the 'diseases which befall a man' and recognized that 'to the human body it makes a great difference whether the bread be fine or coarse; of wheat with or without the hull' ([@b1-vhrm-4-1023]). Indeed, advances in the analysis ([@b74-vhrm-4-1023]) and energy value ([@b11-vhrm-4-1023]) of these 'indigestible carbohydrates' had already been made by the 1930s. However, during the first half of the 20th century, published reports on the functionality of dietary fiber were few and the idea that a group of indigestible plant carbohydrates could facilitate disease prevention did not receive much attention from the nutritional community.

In the 1970s, several researchers including [@b18-vhrm-4-1023], [@b102-vhrm-4-1023], [@b82-vhrm-4-1023], and [@b111-vhrm-4-1023] proposed that the low prevalence of cardiovascular diseases in developing countries was largely due to the consumption of a diet rich in fiber. Following these initial observations, several early epidemiological investigations supported an inverse relationship between dietary fiber consumption and the incidence of coronary heart disease ([@b78-vhrm-4-1023]; [@b115-vhrm-4-1023]; [@b60-vhrm-4-1023]).

One of the earliest researchers to provide experimental evidence in support of a protective role of dietary fiber against coronary heart disease was David Kritchevsky. Kritchevsky was intrigued that saturated fat feeding induced atherosclerosis in rabbits fed semi-purified diets, but not in chow-fed rabbits. Kritchevsky hypothesized that this discrepancy was likely due to the cardioprotective effects associated with dietary fiber components in the commercial chow diets ([@b57-vhrm-4-1023]). The results from Kritchevsky's subsequent experiments supported his initial hypothesis of the cardioprotective effects of dietary fibers ([@b58-vhrm-4-1023], [@b59-vhrm-4-1023]).

Although the dietary fiber hypothesis gained acceptance, a comprehensive definition of dietary fiber was needed in order to effectively study the epidemiological, physiological, and analytical aspects of these indigestible dietary components. However, the development of a comprehensive definition of dietary fiber that satisfied the distinct considerations of nutritionists, food technologists, and food chemists became the subject of great debate. In 1972, Trowell originally defined dietary fiber as 'the skeletal remains of plant cells that are resistant to hydrolysis of the enzymes of man' ([@b103-vhrm-4-1023]). This definition was restricted to plant cell wall components including cellulose, hemicellulose, lignin, and other minor components such as waxes and cutin. This definition was subsequently amended to include plant storage polysaccharides such as gums and pectins, that have similar biological effects of traditional cell wall components, but did not have their origin in structures other than the cell wall ([@b104-vhrm-4-1023]).

With advances in analytical technology and a better understanding of the physiological implications of dietary fiber, the [@b3-vhrm-4-1023] proposed the following comprehensive definition: 'dietary fiber is the edible parts of plants or analogous carbohydrates that are resistant to digestion and absorption in the human small intestine with complete or partial fermentation in the large intestine. Dietary fiber includes polysaccharides, oligosaccharides, lignin, and associated plant substances. Dietary fiber promotes beneficial physiological effects including laxation, and/or blood cholesterol attenuation, and/or blood glucose attenuation'. [@b40-vhrm-4-1023] have criticized physiological-based fiber definitions that stress large intestinal fermentation without including possible interactions of dietary fiber with other dietary components in the upper gastrointestinal tract.

More recently, the Joint FAO/WHO Expert Consultation on Carbohydrates in Human Nutrition ([@b69-vhrm-4-1023]) conceded that a re-evaluation of the fiber definition was warranted and proposed that dietary fiber should be defined as 'intrinsic plant cell wall polysaccharides'.

Current understanding in fiber nutrition
========================================

Classification of dietary fiber
-------------------------------

With years of research supporting the hypolipidemic effects and cardioprotective benefits associated with fiber consumption, recommendations for increased fiber consumption from health authorities around the world are justified ([@b45-vhrm-4-1023]; [@b67-vhrm-4-1023]). However, it is also clear that actual fiber consumption in North America is much lower than what is currently recommended ([@b50-vhrm-4-1023]). This discrepancy may be due to the confusion created by the broad range of substances that are classified under the umbrella of 'dietary fiber' and the lack of knowledge concerning the effect of different fibers on human health ([@b94-vhrm-4-1023]). Dietary fibers are typically classified according to various physical-chemical and physiological criteria including solubility, viscosity, and fermentability ([@b50-vhrm-4-1023]). Generally, soluble fibers such as guar gum (GG), pectin, and psyllium are highly viscous and are readily fermented to short-chain fatty acids (SCFA) in the large bowel in comparison with insoluble fibers such as cellulose ([@b50-vhrm-4-1023]). Furthermore, soluble fibers elicit a much more pronounced hypolipidemic and hypoglycemic response than their insoluble counterparts ([@b32-vhrm-4-1023]).

The variable hypocholesterolemic response to soluble fiber consumption
----------------------------------------------------------------------

Consumption of water-soluble, viscous-forming fibers such as GG, pectin, and psyllium has consistently been shown to reduce plasma cholesterol in human subjects ([@b16-vhrm-4-1023]; [@b56-vhrm-4-1023]; [@b93-vhrm-4-1023]; [@b19-vhrm-4-1023]). The extent of cholesterol lowering in response to fiber consumption is variable, depending on a number of factors including the nature of the background diet, type of dietary fiber, length of adaptation period, and amount of fiber consumed. Furthermore, much of this variability in the plasma lipid-changes reported in response to dietary fiber consumption is thought to have a genetic basis ([@b22-vhrm-4-1023]).

The greatest hypolipidemic effects in response to soluble fiber consumption are seen in animal model investigations where experimental conditions allow fiber intake to be above what is typically observed in humans. Fernandez and colleagues have reported a reduction in total plasma cholesterol up to 43% in guinea pigs fed a high cholesterol (0.25%) diet supplemented with 12.5% GG ([@b95-vhrm-4-1023]). Interestingly, the cholesterol-lowering effect of GG is more pronounced when consumed with a high-cholesterol diet compared with a cholesterol-free diet. In rats fed 7.5% GG, [@b79-vhrm-4-1023] reported total plasma cholesterol reductions of 14 and 32% with cholesterol-free or cholesterol-enriched (0.3%) diets, respectively. Similarly, guinea pigs fed diets supplemented with 12.5% GG responded with a 22% reduction in plasma total cholesterol on a low-cholesterol (0.04%) diet, but demonstrated a 38% reduction in total plasma cholesterol on a high-cholesterol diet (0.25%) ([@b31-vhrm-4-1023]).

Clinical investigations typically report low-density lipoprotein (LDL)-cholesterol reductions in the range of 6%--15% ([@b32-vhrm-4-1023]). Following the consumption of 14 g/d of psyllium in twenty type 2 diabetic patients for 6 weeks, [@b96-vhrm-4-1023] observed a reduction in total and LDL-cholesterol by 7% and 9%, respectively. In addition, a large reduction (25%) in LDL-cholesterol was observed in 24 healthy volunteers receiving 9 g of GG per day for 4 weeks ([@b53-vhrm-4-1023]). Alternatively, a meta analysis of 67 controlled studies by [@b16-vhrm-4-1023] suggested that consumption of 2--10 g of major dietary fibers such as pectin, oat bran, guar gum and psyllium resulted in small but significant reductions in total and LDL-cholesterol. Finally, postprandial circulating lipid concentrations have also been shown to shift favorably following the consumption of dietary fiber. Consumption of a high fiber test meal with 15.7 g of beta-glucan reduced postprandial cholesterol concentrations below the fasting level in 11 healthy men in comparison to a low fiber test meal with 5.0 g of beta-glucan ([@b14-vhrm-4-1023]).

Cholesterol-lowering mechanisms of soluble fibers
-------------------------------------------------

Our traditional understanding of how dietary soluble fibers alter cholesterol metabolism and reduce circulating cholesterol concentrations is illustrated in [Figure 1](#f1-vhrm-4-1023){ref-type="fig"}. It is widely accepted that soluble fibers act primarily in the intestine to promote secondary responses in the liver and peripheral circulation from direct effects within the intestinal lumen ([@b33-vhrm-4-1023]; [@b93-vhrm-4-1023]). One of the primary actions of soluble fibers in the intestine is to reduce dietary fat and cholesterol uptake ([@b93-vhrm-4-1023]). Reductions in apparent intestinal cholesterol absorption have been reported in both human subjects ([@b97-vhrm-4-1023]) and animal models ([@b65-vhrm-4-1023]). Furthermore, *in vitro* cholesterol uptake into everted sacs of rat proximal small intestine from a solution of micelles was reduced by 40% when GG was included in the incubation medium ([@b39-vhrm-4-1023]). It has been proposed that the viscosity associated with soluble fibers interferes with key physiological events in the cholesterol absorptive process. These interference mechanisms include direct binding of cholesterol within the intestinal lumen ([@b9-vhrm-4-1023]), interference with the diffusion of luminal cholesterol toward the epithelial cell surface ([@b93-vhrm-4-1023]), and/or antagonization of the cholesterol emulsification process ([@b76-vhrm-4-1023]). While our knowledge concerning the molecular mechanisms responsible for cholesterol balance within intestinal enterocytes has greatly advanced in recent years, the reduction in cholesterol absorption in response to soluble fiber consumption is most often attributed to viscosity with very little emphasis on the potential regulation of proteins that mediate intestinal cholesterol absorption ([@b28-vhrm-4-1023]).

The hypocholesterolemic effects of soluble fibers are also believed to result from an interference with the enterohe-patic circulation of bile acids ([@b32-vhrm-4-1023]). [@b72-vhrm-4-1023] concluded that the consumption of oat bran in normolipidemic young men decreased serum cholesterol by altering the composition of the enterohepatic bile acid pool and increasing the fecal loss of total bile acids. These observations were further demonstrated in human clinical studies by [@b66-vhrm-4-1023], [@b10-vhrm-4-1023], and [@b29-vhrm-4-1023]. The dietary supplementation of psyllium at a level of 10% is associated with a dose-dependent increase in fecal bile acid excretion in rats ([@b17-vhrm-4-1023]). Similarly, native amylo-maize resistant starch, a modified starch with similar physiological effects to soluble fibers, has been shown to increase the fecal excretion of primary bile acids in human subjects ([@b108-vhrm-4-1023]). Interestingly, while GG was traditionally thought to reduce intestinal bile acid uptake, a series of reports in the late 1990's suggest that intestinal bile acid flux to the liver may actually be increased in response to GG consumption ([@b30-vhrm-4-1023]; [@b79-vhrm-4-1023]; [@b77-vhrm-4-1023]). Therefore, the traditional mechanisms by which GG reduces plasma cholesterol concentrations may have to be re-evaluated.

The reduction in intestinal cholesterol absorption and bile acid uptake in response to soluble fiber consumption are believed to alter hepatic cholesterol homeostasis by effectively reducing cholesterol concentrations in the liver by two related mechanisms. Firstly, a decrease in the delivery of dietary cholesterol to the liver through chylomicron remnants results in a direct reduction in the hepatic cholesterol pool ([@b32-vhrm-4-1023]). The dietary supplementation of GG at 12.5% has been shown to reduce hepatic free and esterified cholesterol levels by 21% and 16%, respectively, in guinea pigs ([@b31-vhrm-4-1023]). Secondly, an increase in the fecal loss of bile acids and a reduction in the enterohepatic bile acid pool size may stimulate the liver to produce more bile acids from cholesterol, thus reducing hepatic free cholesterol concentrations ([@b107-vhrm-4-1023]).

The increased hepatic demand for cholesterol from the fiber-induced reduction in hepatic microsomal free cholesterol pool can be met by increasing the uptake of lipoprotein cholesterol from the plasma, the release of free cholesterol from intracellular storage of cholesteryl ester and membrane cholesterol, or by increasing hepatic cholesterol synthesis ([@b32-vhrm-4-1023]; [@b88-vhrm-4-1023]). Consumption of various types of soluble fibers has been shown to increase the fractional catabolic rate of LDL ([@b110-vhrm-4-1023]) and hepatic LDLr expression ([@b31-vhrm-4-1023]; Fukishima et al 2001; [@b42-vhrm-4-1023]).

A compensatory increase in the expression of hepatic HMG-CoA reductase, the rate--limiting enzyme in cholesterol biosynthesis, is thought to account for the reduction in the hepatic free cholesterol pool following the consumption of GG ([@b30-vhrm-4-1023]), manufactured soluble fiber from wood chips ([@b24-vhrm-4-1023]), psyllium ([@b17-vhrm-4-1023]), and pectin ([@b38-vhrm-4-1023]). It has been suggested that GG elicits a hypocholesterolemic effect even in the face of an increase in hepatic cholesterol synthesis, as the increase in HMG-CoAr activity is not sufficient to compensate for fecal steroid loss in rats fed a diet supplemented with 7.5% GG ([@b79-vhrm-4-1023]).

The reduction in hepatic free cholesterol concentrations following soluble fiber consumption is thought to lead to a modification of hepatic lipoprotein metabolism. Soluble fiber consumption has been associated with a reduction in hepatic apolipoprotein B secretion and the formation of large triglyceride-rich, cholesteryl-ester-depleted very LDL (VLDL) particles ([@b32-vhrm-4-1023]). This change in the endogenous cholesterol pathway results in a VLDL particle that is less prone to IDL and LDL conversion via extrahepatic lipases and LDL particles with a high peak density ([@b92-vhrm-4-1023]; [@b32-vhrm-4-1023]).

The production of SCFA by bacterial fermentation in the large intestine is thought to have multiple health benefits and may be involved in mediating the hypocholesterolemic effects of dietary fiber ([@b25-vhrm-4-1023]). Furthermore, dietary fibers with unique physiochemical properties elicit differential SCFA profiles in the large intestine ([@b87-vhrm-4-1023]). Strong evidence for this SCFA-induced hypocholesterolemic effect from fiber fermentation comes from the observation that the cholesterol-lowering action of beet pulp disappears in rats following the removal of the cecum, both the cecum and colon, but not upon the removal of the colon alone ([@b81-vhrm-4-1023]). However, the reduction in total cholesterol, LDL-cholesterol, and apolipoprotein B concentrations in ileostomy subjects fed an oat bran based high fiber diet suggests that large intestinal fiber fermentation is not necessary for cholesterol-reductions in human subjects ([@b118-vhrm-4-1023]). Particular emphasis has been placed on the role of butyrate as a signaling molecule that is important in regulating intestinal function and systemic cholesterol metabolism ([@b71-vhrm-4-1023]). Moreover, it has recently been suggested that butyrate may impair the assembly of triglyceride-rich lipoproteins within intestinal enterocytes, as a decrease in the basolateral efflux of cholesteryl ester in response to butyrate has been demonstrated in Caco-2 cells ([@b70-vhrm-4-1023]).

Research priorities in dietary fiber and cholesterol metabolism
===============================================================

Individual physiological responses to dietary fibers
----------------------------------------------------

The future of functional foods in modulating human health is closely connected to the concept of 'personalized nutrition' ([@b106-vhrm-4-1023]). The ability to specifically tailor dietary treatment based on individual genetic polymorphisms will bolster the importance of the diet in disease prevention and potentially revolutionize the world's health care system. Although dietary factors are effective modulators of cellular metabolism at the molecular level, it is becoming increasingly clear that there is considerable variability in the response of plasma lipids to various nutritional lipid-lowering therapies including plant sterols ([@b52-vhrm-4-1023]) and dietary fibers ([@b22-vhrm-4-1023]). This variable inter-individual response is in part due to single base variations within gene sequences that function as molecular targets of dietary bioactive components ([@b105-vhrm-4-1023]). Although the influence of genetic polymorphisms on the lipoprotein profile in response to plant sterols ([@b83-vhrm-4-1023]), dietary cholesterol ([@b91-vhrm-4-1023]), and soy isoflavones ([@b41-vhrm-4-1023]) have been extensively studied, the role of genotype in determining the hypocholesterolemic effects of dietary fibers has been the subject of few investigations.

Apolipoprotein E (ApoE), the major apoprotein component of chylomicrons, is polymorphic and thought to influence the response of plasma lipids to dietary intervention strategies ([@b117-vhrm-4-1023]). Jenkins' group has addressed the association between gene polymorphisms and the lipid-lowering response to dietary fiber consumption in three separate publications. In the first of these publications, [@b51-vhrm-4-1023] examined the association between the three common apo E alleles (E2, E3, and E4) and the plasma cholesterol response observed in 67 volunteers who completed a controlled dietary intervention that included a 2 week consumption of oat bran or wheat bran at a level of 6.8 g fiber/1000 kcal. Total cholesterol, LDL-cholesterol, and apolipoprotein B (ApoB) concentrations were significantly lower in subjects heterozygous for the E2 allele following fiber consumption in comparison to the E3 homozygotes and E4 carriers. However, a more recent study by [@b114-vhrm-4-1023], using 22, 915 free-living participants from the European Prospective Investigation of Cancer Norfolk study, suggest that ApoE genotype does not reflect changes in plasma cholesterol profile in response to dietary fat or fiber intake. The authors propose that the apparent controversy surrounding the role of ApoE phenotypes in the serum lipid response to diet is likely due to the lack of statistical power associated with the small sample size used as part of the experimental design in previous investigations. In a second study from the Jenkins lab, [@b47-vhrm-4-1023] hypothesized that polymorphisms in genes regulating ApoB metabolism, including the low-density lipoprotein receptor (LDLr), ApoB, apolipoprotein CIII (ApoCIII), and hepatic lipase, could influence the fiber-related reduction of ApoB containing lipoproteins. The results of this investigation suggested that LDLr genotype had a significant impact on the plasma lipid response following dietary fiber consumption. Finally, a preliminary investigation by [@b46-vhrm-4-1023] suggested that genetic variations in the fatty acid binding protein 2 gene, involved in regulating intestinal fatty acid absorption and intracellular transport ([@b44-vhrm-4-1023]), may be involved in modulating the reductions in plasma cholesterol in response to dietary fiber consumption. However, the authors suggest that the results be interpreted with caution due to the small sample size (n = 43) and the marginality associated with some of the statistical outcomes.

As can be seen from the above discussion, published reports on the role of gene polymorphism in the cholesterol-lowering response to soluble fibers are few and often limited by small sample size. The hypocholesterolemic effects of dietary fibers are initiated by primary intestinal events related to the digestion and absorption of dietary fat and cholesterol ([@b62-vhrm-4-1023]). Therefore, investigation into the association between polymorphisms in genes that regulate intestinal triglyceride and cholesterol digestion and plasma lipoprotein outcomes in response to soluble fiber consumption may be prudent. Indeed, pancreatic triglyceride lipase and carboxyl ester lipase, two enzymes involved in intestinal triglyceride and cholesterol digestion, have been shown to be highly polymorphic and may therefore explain some of the variability associated with dietary fiber consumption (Lidberge et al 1992; [@b21-vhrm-4-1023]).

The 'omics' approach to dietary fiber research
----------------------------------------------

The focus of modern day nutrition research is shifting with the advent of novel, high-throughput investigative tools that permit an examination of how nutrients affect the global expression and characterization of transcripts, proteins, and metabolites ([@b2-vhrm-4-1023]). The application of multiplexing technology involved in nutrigenomics, nutri-epigenetics, transcriptomics, proteomics, and metabolomics will advance our understanding of nutrient-gene-metabolite interactions and ultimately lead to the identification of novel biomarkers of disease risk and the development of effective functional food products ([@b105-vhrm-4-1023]). Although this 'omics' approach to nutrition may currently be limited by its high expense and the need for highly qualified individuals to analyze and integrate the vast amount of data that are generated, it has given us valuable insight into how the consumption of various dietary ingredients, including dietary fat ([@b54-vhrm-4-1023]), soy isoflavones ([@b36-vhrm-4-1023]), dietary zinc ([@b13-vhrm-4-1023]), and plant sterols ([@b20-vhrm-4-1023]), affect global gene expression and cell metabolism. However, very few published reports have applied 'omic' technology to the dietary fiber field. One exception has been a recently published report by [@b35-vhrm-4-1023] who applied a proteomic approach to study the effect of flaxseed consumption on differentially expressed genes in human peripheral blood mononuclear cells. Flaxseed consumption at a level of 0.4 g/kg BW for 7 days, resulted in 16 differentially expressed proteins compared with the control group. This differential protein expression pattern included enhanced levels of peroxiredoxin and reduced expression of long-chain fatty acid β-oxidation multienzyme complex and glycoprotein IIIa/II, suggestive of an antithrombotic and anti-inflammatory effect from the flaxseed treatment. Microarray technology has also been employed to study the mechanisms by which intestinal SCFA produced from fiber fermentation in the large intestine affect the progression of colon cancers ([@b73-vhrm-4-1023]; [@b26-vhrm-4-1023]). Given the heterogeneity associated with dietary fibers, it is likely that fiber sources with different physiochemical properties will produce a unique metabolic 'footprint'. Furthermore, the movement of nutrition research from a reductionist science to a systems biology approach will allow the integration of complex biological information at the gene, protein, and metabolite level and advance our understanding of the role of dietary soluble fiber in achieving optimal personalized health.

Regulation of genes and protein expression within the enterohepatic loop
------------------------------------------------------------------------

In order to avoid the potential atherogenic consequences associated with elevated plasma cholesterol, elaborate regulatory mechanisms have evolved to balance the intestinal absorption and *de novo* synthesis of cholesterol (the major input pathways) with biliary cholesterol and bile acid excretion (the major output pathways) ([@b64-vhrm-4-1023]). Our understanding of the molecular regulators of enterohepatic cholesterol and bile acid metabolism has been greatly advanced through the characterization of the major proteins involved in maintaining sterol balance at the intestinal and hepatic levels ([Figure 2](#f2-vhrm-4-1023){ref-type="fig"}). Within the intestine, cholesterol absorption and efflux appear to be regulated largely through the brush-border membrane proteins Niemann-Pick C like 1 and ATP-binding cassette G5 and G8, respectively ([@b61-vhrm-4-1023]). At the hepatic level, the clearance of plasma LDL and HDL-cholesterol occurs through the LDLr and the scavenger receptor class B, type 1 (SR-B1) while cholesterol synthesis and oxidation is precisely controlled through activity of the rate-limiting enzymes HMG-CoAr and cholesterol 7α-hydroxylase (CYP7A1), respectively ([@b27-vhrm-4-1023]). Furthermore, the influence of hepatic ABCG5/G8 expression on biliary cholesterol secretion and intestinal cholesterol absorption has only recently been recognized ([@b113-vhrm-4-1023]; [@b89-vhrm-4-1023]). Finally, numerous nuclear receptors (eg, LXR, FXR) and transcription factors (eg, SREBP2) have been shown to be critical in modulating transcriptional events and maintaining cholesterol homeostasis within the enterohepatic loop ([@b112-vhrm-4-1023]).

Information concerning the effect of dietary fiber consumption on the expression of genes that regulate intestinal cholesterol absorption and hepatic sterol balance is limited. For the most part, published reports on the molecular mechanisms associated with the hypocholesterolemic effects of dietary fibers have pertained to the hepatic mRNA expression of HMG-CoAr and CYP7A1 ([@b48-vhrm-4-1023]; [@b55-vhrm-4-1023]; [@b42-vhrm-4-1023]). Although these studies have provided insight into how fibers may affect metabolism at the gene level, the expression of a gene from DNA to protein is a complex process with control mechanisms that regulate multiple steps including transcription rate, nuclear export and mRNA localization, transcript stability, translational efficiency, protein degradation, and post-translational processing ([@b84-vhrm-4-1023]; [@b43-vhrm-4-1023]; [@b116-vhrm-4-1023]). Therefore, cellular mRNA levels are often unreliable indicators of protein abundances, and the abundance of any particular protein does not necessarily reflect its catalytic activity ([@b43-vhrm-4-1023]). In an effort to more fully characterize the hypocholester-olemic effects of soluble fiber at the molecular level, our recent work proposes several novel mechanisms by which GG may exert its effects. Firstly, our data suggests that the hypocholesterolemic effects of GG consumption are mediated by a reduction in hepatic free-cholesterol concentration and an associated SREBP2-dependent increase in hepatic LDLr mRNA and protein expression ([@b88-vhrm-4-1023]). At the transcriptional level, hepatic cholesterol metabolism is tightly controlled through SREBP2, a nuclear receptor that binds to sterol response elements in the promoter region of a multitude of target genes ([@b49-vhrm-4-1023]). In the absence of a change in SREBP2 mRNA, we observed an increase in the cytoplasmic precursor and nuclear active forms of SREBP2 without a corresponding increase in the cytoplasmic mature form of the protein in response to GG consumption. This differential expression pattern suggests GG consumption may have increased nuclear SREBP2 expression through mechanisms independent of protease-dependent cleavage at the Golgi.

Secondly, in response to GG consumption we observed an increase in hepatic ABCG5/G8 mRNA and protein expression and biliary cholesterol concentration in comparison to the control-fed pigs ([@b86-vhrm-4-1023]; [@b89-vhrm-4-1023]). Traditionally, by interfering with the enterohepatic circulation and intestinal uptake of bile acids, soluble fiber consumption is believed to modulate whole-body cholesterol excretion through stimulation of cholesterol catabolism to bile acids ([@b101-vhrm-4-1023]). However, an additional quantitatively important route of cholesterol excretion occurs through the biliary secretion and eventual fecal loss of free cholesterol ([@b98-vhrm-4-1023]). Our recent data suggest that the stimulation of biliary free cholesterol secretion through hepatic ABCG5/G8 may exist as a novel mechanism by which GG consumption stimulates whole-body cholesterol loss and effectively reduces plasma cholesterol concentrations ([@b86-vhrm-4-1023]; [@b89-vhrm-4-1023]).

Both targeted traditional molecular approaches and novel high-throughput technology may be employed to gain a more comprehensive understanding of how dietary soluble fiber consumption regulates gene and protein express patterns. Unlike other dietary bioactive components that are thought to directly regulate the transcription of hepatic cholesterol-responsive genes ([@b75-vhrm-4-1023]), dietary fiber components are not absorbed from the gastrointestinal tract and therefore are generally thought to influence hepatic cholesterol homeostasis through secondary signaling systems and metabolites ([@b31-vhrm-4-1023]). Therefore, to fully delineate the molecular events by which soluble fiber consumption modulates peripheral cholesterol metabolism, it will be critical to determine the molecular signals that are involved in mediating these secondary effects.

Conclusions
===========

Although dietary fiber may be considered a 'dinosaur' among other functional foods, it should not be perceived as extinct. The future relevance of functional fiber-based foods will depend on the ability to integrate consumer health concerns with a comprehensive understanding of the health benefits and disease-prevention potential of unique varieties of soluble fibers. Due to the specific physical-chemical attributes that are associated with fibers that originate from different plant sources and produced with alternative processing technologies, dietary fibers are unique functional ingredients that have wide-ranging appeal in the functional food community. While the hypocholesterolemic effects associated with soluble fiber consumption are clear, a comprehensive understanding of these effects, particularly at the molecular level, will require additional exploration. Advances in understanding the variable interindividual response to dietary soluble fibers and the effect of fiber consumption on expression patterns at the gene, protein and metabolite level will advance through application of traditional molecular tools and novel high-throughput technology. Detailed knowledge of the mechanisms by which different soluble fibers reduce plasma cholesterol concentrations is paramount to developing novel fiber-based "cocktails" and portfolio-type diets that target specific metabolic pathways to gain maximal cholesterol reductions.
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